Investment Rating - The investment rating for the company is "Buy" with a 6-month outlook maintained [5]. Core Insights - The company has established itself as a leader in the domestic adult incontinence market, holding the number one market share for several consecutive years, supported by strong brand recognition [2]. - The company is expanding its product categories and optimizing its product structure to meet the evolving consumer demands, particularly focusing on mid-to-high-end products [3]. - The financial performance for the first half of 2025 shows a revenue of 550 million with a year-on-year growth of 5%, and a net profit of 28 million, reflecting a 22% increase [1][4]. Financial Performance Summary - For Q2 2025, the company reported revenue of 270 million, a 13% increase year-on-year, and a net profit of 10 million, which is a 98% increase [1]. - The revenue breakdown for H1 2025 includes adult incontinence products at 290 million (5% growth), baby care products at 210 million (6% growth), and pet hygiene products at 34 million (1% decline) [1]. - The adjusted profit forecast for 2025-2027 estimates net profits of 36 million, 43 million, and 50 million respectively, reflecting a steady growth trajectory [4]. Product Development and Market Strategy - The company is focusing on product innovation to address user pain points, such as odor control and breathability, thereby creating a differentiated competitive advantage [2]. - New product launches include discreet absorbent pads designed for Asian women and specialized men's absorbent products, expanding the product line further [3]. - The company aims to leverage its strong brand effect and cost leadership by enhancing its supply chain and product offerings [2].
可靠股份（301009）：拓展产品品类，形成丰富的产品线梯队